Logo image of BWAY

BRAINSWAY LTD-ADR (BWAY) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:BWAY - US10501L1061 - ADR

23.11 USD
+0.02 (+0.09%)
Last: 1/9/2026, 8:00:01 PM
22.7 USD
-0.41 (-1.77%)
After Hours: 1/9/2026, 8:00:01 PM
Fundamental Rating

6

BWAY gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 185 industry peers in the Health Care Equipment & Supplies industry. BWAY has an excellent financial health rating, but there are some minor concerns on its profitability. BWAY is evaluated to be cheap and growing strongly. This does not happen too often! With these ratings, BWAY could be worth investigating further for value and growth investing!.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year BWAY was profitable.
In the past year BWAY had a positive cash flow from operations.
In the past 5 years BWAY reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: BWAY reported negative operating cash flow in multiple years.
BWAY Yearly Net Income VS EBIT VS OCF VS FCFBWAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

BWAY's Return On Assets of 5.53% is amongst the best of the industry. BWAY outperforms 82.70% of its industry peers.
BWAY's Return On Equity of 8.92% is amongst the best of the industry. BWAY outperforms 83.24% of its industry peers.
BWAY has a better Return On Invested Capital (2.75%) than 69.73% of its industry peers.
Industry RankSector Rank
ROA 5.53%
ROE 8.92%
ROIC 2.75%
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
BWAY Yearly ROA, ROE, ROICBWAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

The Profit Margin of BWAY (12.73%) is better than 89.19% of its industry peers.
The Operating Margin of BWAY (5.78%) is better than 70.81% of its industry peers.
BWAY has a Gross Margin of 74.92%. This is amongst the best in the industry. BWAY outperforms 85.41% of its industry peers.
BWAY's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.78%
PM (TTM) 12.73%
GM 74.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
BWAY Yearly Profit, Operating, Gross MarginsBWAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BWAY is destroying value.
BWAY has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BWAY has been increased compared to 5 years ago.
Compared to 1 year ago, BWAY has a worse debt to assets ratio.
BWAY Yearly Shares OutstandingBWAY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
BWAY Yearly Total Debt VS Total AssetsBWAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

BWAY has an Altman-Z score of 6.34. This indicates that BWAY is financially healthy and has little risk of bankruptcy at the moment.
BWAY's Altman-Z score of 6.34 is amongst the best of the industry. BWAY outperforms 81.62% of its industry peers.
The Debt to FCF ratio of BWAY is 0.37, which is an excellent value as it means it would take BWAY, only 0.37 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of BWAY (0.37) is better than 92.43% of its industry peers.
BWAY has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.08, BWAY is in the better half of the industry, outperforming 65.95% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.37
Altman-Z 6.34
ROIC/WACC0.32
WACC8.57%
BWAY Yearly LT Debt VS Equity VS FCFBWAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

BWAY has a Current Ratio of 3.19. This indicates that BWAY is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of BWAY (3.19) is comparable to the rest of the industry.
A Quick Ratio of 3.02 indicates that BWAY has no problem at all paying its short term obligations.
BWAY's Quick ratio of 3.02 is fine compared to the rest of the industry. BWAY outperforms 66.49% of its industry peers.
Industry RankSector Rank
Current Ratio 3.19
Quick Ratio 3.02
BWAY Yearly Current Assets VS Current LiabilitesBWAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 260.14% over the past year.
The Revenue has grown by 27.08% in the past year. This is a very strong growth!
The Revenue has been growing by 12.17% on average over the past years. This is quite good.
EPS 1Y (TTM)260.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.08%
Revenue 1Y (TTM)27.08%
Revenue growth 3Y11.41%
Revenue growth 5Y12.17%
Sales Q2Q%16.38%

3.2 Future

BWAY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 54.11% yearly.
Based on estimates for the next years, BWAY will show a quite strong growth in Revenue. The Revenue will grow by 18.80% on average per year.
EPS Next Y68.53%
EPS Next 2Y55.05%
EPS Next 3Y54.11%
EPS Next 5YN/A
Revenue Next Year13.72%
Revenue Next 2Y17.9%
Revenue Next 3Y18.8%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BWAY Yearly Revenue VS EstimatesBWAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
BWAY Yearly EPS VS EstimatesBWAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 -2

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 21.60, BWAY is valued on the expensive side.
82.16% of the companies in the same industry are more expensive than BWAY, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.19. BWAY is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 16.23 indicates a correct valuation of BWAY.
Based on the Price/Forward Earnings ratio, BWAY is valued cheaper than 87.03% of the companies in the same industry.
BWAY is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.92, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 21.6
Fwd PE 16.23
BWAY Price Earnings VS Forward Price EarningsBWAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

BWAY's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. BWAY is cheaper than 64.32% of the companies in the same industry.
BWAY's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BWAY is cheaper than 84.86% of the companies in the same industry.
Industry RankSector Rank
P/FCF 24.65
EV/EBITDA 81.61
BWAY Per share dataBWAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BWAY's earnings are expected to grow with 54.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.32
PEG (5Y)N/A
EPS Next 2Y55.05%
EPS Next 3Y54.11%

0

5. Dividend

5.1 Amount

BWAY does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

BRAINSWAY LTD-ADR

NASDAQ:BWAY (1/9/2026, 8:00:01 PM)

After market: 22.7 -0.41 (-1.77%)

23.11

+0.02 (+0.09%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-11 2025-11-11/dmh
Earnings (Next)03-09 2026-03-09/bmo
Inst Owners4.9%
Inst Owner Change0.01%
Ins Owners16.11%
Ins Owner ChangeN/A
Market Cap452.05M
Revenue(TTM)49.09M
Net Income(TTM)6.25M
Analysts85.71
Price Target0.12 (-99.48%)
Short Float %0.47%
Short Ratio1.11
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)65.34%
Min EPS beat(2)35.56%
Max EPS beat(2)95.12%
EPS beat(4)3
Avg EPS beat(4)50.32%
Min EPS beat(4)-22.64%
Max EPS beat(4)95.12%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.57%
Min Revenue beat(2)-1.07%
Max Revenue beat(2)-0.08%
Revenue beat(4)1
Avg Revenue beat(4)-0.87%
Min Revenue beat(4)-2.35%
Max Revenue beat(4)0.01%
Revenue beat(8)4
Avg Revenue beat(8)-0.3%
Revenue beat(12)6
Avg Revenue beat(12)-11.32%
Revenue beat(16)6
Avg Revenue beat(16)-26.49%
PT rev (1m)4.17%
PT rev (3m)10.57%
EPS NQ rev (1m)-6.27%
EPS NQ rev (3m)-0.9%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.45%
Revenue NQ rev (1m)-3.81%
Revenue NQ rev (3m)-5.49%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.12%
Valuation
Industry RankSector Rank
PE 21.6
Fwd PE 16.23
P/S 9.21
P/FCF 24.65
P/OCF 20.3
P/B 6.45
P/tB 6.45
EV/EBITDA 81.61
EPS(TTM)1.07
EY4.63%
EPS(NY)1.42
Fwd EY6.16%
FCF(TTM)0.94
FCFY4.06%
OCF(TTM)1.14
OCFY4.93%
SpS2.51
BVpS3.58
TBVpS3.58
PEG (NY)0.32
PEG (5Y)N/A
Graham Number9.29
Profitability
Industry RankSector Rank
ROA 5.53%
ROE 8.92%
ROCE 3.26%
ROIC 2.75%
ROICexc 15.43%
ROICexgc 15.43%
OM 5.78%
PM (TTM) 12.73%
GM 74.92%
FCFM 37.36%
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
F-Score5
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.37
Debt/EBITDA 1.21
Cap/Depr 207.6%
Cap/Sales 8.01%
Interest Coverage 26.28
Cash Conversion 470.69%
Profit Quality 293.55%
Current Ratio 3.19
Quick Ratio 3.02
Altman-Z 6.34
F-Score5
WACC8.57%
ROIC/WACC0.32
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)260.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.08%
EPS Next Y68.53%
EPS Next 2Y55.05%
EPS Next 3Y54.11%
EPS Next 5YN/A
Revenue 1Y (TTM)27.08%
Revenue growth 3Y11.41%
Revenue growth 5Y12.17%
Sales Q2Q%16.38%
Revenue Next Year13.72%
Revenue Next 2Y17.9%
Revenue Next 3Y18.8%
Revenue Next 5YN/A
EBIT growth 1Y147.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year6.54%
EBIT Next 3Y43.13%
EBIT Next 5YN/A
FCF growth 1Y441.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y749.36%
OCF growth 3Y127.03%
OCF growth 5YN/A

BRAINSWAY LTD-ADR / BWAY FAQ

What is the fundamental rating for BWAY stock?

ChartMill assigns a fundamental rating of 6 / 10 to BWAY.


Can you provide the valuation status for BRAINSWAY LTD-ADR?

ChartMill assigns a valuation rating of 7 / 10 to BRAINSWAY LTD-ADR (BWAY). This can be considered as Undervalued.


How profitable is BRAINSWAY LTD-ADR (BWAY) stock?

BRAINSWAY LTD-ADR (BWAY) has a profitability rating of 5 / 10.


Can you provide the expected EPS growth for BWAY stock?

The Earnings per Share (EPS) of BRAINSWAY LTD-ADR (BWAY) is expected to grow by 68.53% in the next year.